SCHEMBL9627396

SCHEMBL9627396

CC(C)C1=C(Cl)C(=O)c2ccccc2C1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.62
DNMT1 P26358 1/20 0.62
DNMT3L Q9UJW3 1/20 0.62
DNMT3A Q9Y6K1 1/20 0.62
MAPT P10636 6/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
LMNA P02545 4/20 0.53
ALDH1A1 P00352 2/20 0.53
KDM4E B2RXH2 2/20 0.53
HPGD P15428 1/20 0.53
CDC25B P30305 5/20 0.48
CDC25A P30304 4/20 0.48
HTT P42858 4/20 0.47
MITF O75030 3/20 0.47
POLB P06746 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
USP2 O75604 1/20 0.47
HSP90AA1 P07900 2/20 0.46
HSP90AB1 P08238 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627830 0.81 CDC25A (0.49) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL9627565 0.80 IDO1 (0.54) IDO1DNMT1DNMT3LDNMT3AMAPT
Dichlon SCHEMBL29360991 0.78 IDO1 (1.00) IDO1DNMT1DNMT3LDNMT3AMAPT
Dichlon SCHEMBL9751236 0.78 IDO1 (1.00) IDO1DNMT1DNMT3LDNMT3AMAPT
Dichlon SCHEMBL45723 0.78 IDO1 (1.00) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL31267509 0.78 CES2 (0.39) IDO1DNMT1DNMT3LDNMT3AMAPT
Dichlon SCHEMBL10794085 0.76 IDO1 (0.94) IDO1DNMT1DNMT3LDNMT3AMAPT
Dichlon SCHEMBL5077878 0.76 IDO1 (0.94) IDO1DNMT1DNMT3LDNMT3AMAPT
SCHEMBL22874151 0.76 CDC25B (0.54) IDO1MAPTMEN1KMT2ALMNA
SCHEMBL9324815 0.75 IDO1 (0.58) IDO1DNMT1DNMT3LDNMT3AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed
US-4507241-A Method for the hydrocarbylation of naphthoquinone derivatives E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-03-26 US disclosed